Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 11,444 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 22 to Jun 23, 2026 · Filed Jun 24, 2026

From Jun 22 to Jun 23, 2026, Pham Quang X (Director, Chairman, CEO and Interim CFO, 10% owner) sold 11,444 Cadrenal Therapeutics, Inc. shares at an average US$3.48 for US$39,829 under a trading plan, leaving 117,145 shares. Filed Jun 24, 2026 (Form 4).

Sold
11,444 shares
Price
US$3.48 average (US$3.20 to US$3.55)
Value
US$39,829
Holding after
117,145 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairman, CEO and Interim CFO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockSale9,167US$3.55119,422Direct
Jun 23, 2026Common StockSale2,277US$3.20117,145Direct

Source

View original at SEC

Related